Farallon Capital Management, L.L.C.
In its 13F for Q2 2026 (holdings as of June 30, 2026, filed August 14, 2026), Farallon Capital Management, L.L.C. reported 77 stock positions worth $16.9 billion. Its top holding was Revolution Medicines (RVMD) at 15.0% of the portfolio, followed by Electronic Arts (EA, 9.6%) and Bridgebio Pharma (BBIO, 4.7%). Compared with Q1 2026, it opened 18 new positions, sold out of 104, added to 28 and reduced 22. The biggest buy was Roivant Sciences (ROIV, shares +48%) and the biggest sale Microsoft (MSFT, shares −53%).
- Most Recent 13F
- Q2 2026
- Location
- SAN FRANCISCO, CA
- CIK
- 0000909661
- Portfolio Value
- $16.9B (Q2 2026)
- SEC Filing
- 0000908834-26-000432 ↗ filed Aug 14, 2026
Holdings Value
Holdings 77 stocks · $16.9B
| RVMD Revolution Medicines Inc. | 14.98% | 13,550,796 | $2.5B | Reduce -0.4% |
| EA Electronic Arts Inc. | 9.58% | 7,919,500 | $1.6B | Add +6.0% |
| BBIO Bridgebio Pharma Inc. | 4.72% | 10,743,063 | $800.1M | Add +14.7% |
| PTGX Protagonist Therapeutics Inc. | 4.59% | 6,348,906 | $778.2M | No change |
| EXEL Exelixis Inc. | 4.33% | 13,468,010 | $732.8M | Add +2.7% |
| LQDA Liquidia Corp. | 3.94% | 8,365,038 | $666.9M | Reduce -3.4% |
| AMZN Amazon.com Inc. | 3.70% | 2,632,994 | $627.5M | Reduce -37.6% |
| LNTH Lantheus Holdings Inc. | 3.66% | 5,583,479 | $619.4M | No change |
| NTRA Natera Inc. | 3.55% | 2,218,366 | $602.2M | Reduce -30.8% |
| UNH Unitedhealth Group Inc. | 3.12% | 1,270,532 | $528.1M | Reduce -30.3% |
| TMO Thermo Fisher Scientific Inc. | 3.10% | 1,049,185 | $526.0M | Add +19.0% |
| ROIV Roivant Sciences Ltd. | 2.99% | 14,309,000 | $506.4M | Add +47.9% |
| AON Aon PLC Class A | 2.71% | 1,382,562 | $458.6M | Reduce -45.0% |
| BSX Boston Scientific Corp. | 2.65% | 10,521,184 | $449.0M | Add +40.8% |
| AVGO Broadcom Inc. | 2.57% | 1,151,800 | $435.1M | Reduce -35.3% |
| MSFT Microsoft Corp. | 2.45% | 1,112,863 | $415.1M | Reduce -52.5% |
| TNGX Tango Therapeutics Inc. | 2.27% | 12,277,000 | $383.8M | Add +35.0% |
| KKR KKR & Co. Inc. | 2.23% | 4,118,300 | $378.0M | Reduce -11.8% |
| SNPS Synopsys Inc. | 2.18% | 829,600 | $370.1M | Reduce -31.6% |
| BEAM Beam Therapeutics Inc. | 2.07% | 10,236,396 | $351.3M | Add +1.0% |
| CRNX Crinetics Pharmaceuticals Inc. | 1.99% | 8,989,098 | $336.4M | Add +7.8% |
| GRAL Grail Inc. | 1.68% | 4,161,584 | $284.1M | Add +27.9% |
| WAB Wabtec Corp. | 1.42% | 894,503 | $241.2M | Reduce -44.4% |
| IMVT Immunovant Inc. | 1.32% | 5,805,000 | $223.7M | Add +275.5% |
| TWST Twist Bioscience Corp. | 1.30% | 2,136,400 | $219.8M | Add +49.6% |
| AGIO Agios Pharmaceuticals Inc. | 1.30% | 5,917,400 | $219.6M | Add +4.1% |
| ARMK Aramark | 1.22% | 3,625,731 | $206.3M | Reduce -40.9% |
| BIDU Baidu Inc. - Spon ADR | 0.81% | 1,203,785 | $137.6M | Add +171.3% |
| NVO Novo-Nordisk A/S-Spons ADR | 0.74% | 2,619,000 | $125.6M | Add +234.9% |
| ACHC Acadia Healthcare Co. Inc. | 0.74% | 4,220,800 | $124.6M | Add +143.0% |
| BTSG Brightspring Health Services | 0.71% | 1,732,800 | $120.8M | Add +7.2% |
| AZN Astrazeneca PLC | 0.64% | 574,000 | $108.8M | Add +153.4% |
| JNJ Johnson & Johnson | 0.61% | 408,000 | $103.6M | Add +175.7% |
| PBLS Parabilis Medicines Inc. | 0.38% | 2,368,200 | $64.8M | New |
| NVS Novartis AG-Sponsored ADR | 0.34% | 363,000 | $56.9M | New |
| GH Guardant Health Inc. | 0.29% | 322,200 | $48.3M | Add +3927.5% |
| AVTX Avalo Therapeutics Inc. | 0.27% | 2,498,000 | $46.2M | Add +172.7% |
| JOYY Joyy Inc.-ADR | 0.27% | 699,200 | $46.1M | Add +20.9% |
| ASMB Assembly Biosciences Inc. | 0.26% | 1,604,590 | $44.1M | Add +30.7% |
| ENTA Enanta Pharmaceuticals Inc. | 0.21% | 2,418,202 | $35.3M | Reduce -15.8% |
| MAZE Maze Therapeutics Inc. | 0.20% | 1,107,814 | $33.1M | Add +197.0% |
| MRK Merck & Co. Inc. | 0.15% | 199,000 | $25.6M | Reduce -44.9% |
| WRBY Warby Parker Inc. Class A | 0.15% | 828,000 | $25.1M | New |
| FRNM Freenome Inc. filed as PERCEPTIVE CAP SOLUTIONS COR | 0.14% | 2,250,000 | $24.5M | No change |
| KLRA Kailera Therapeutics Inc. | 0.14% | 1,100,000 | $24.2M | New |
| RIO Rio Tinto PLC-Spon ADR | 0.10% | 183,475 | $17.4M | Add +241.0% |
| AXTA Axalta Coating Systems Ltd. | 0.10% | 478,000 | $16.4M | New |
| ABVX Abivax SA-ADR | 0.10% | 122,000 | $16.3M | Add +6000.0% |
| VNET Vnet Group Inc.-ADR | 0.09% | 1,992,000 | $16.0M | Add +219.6% |
| NTES Netease Inc.-ADR | 0.09% | 123,500 | $15.8M | Reduce -57.6% |
| BIIB Biogen Inc. | 0.09% | 71,000 | $15.3M | New |
| TSHA Taysha Gene Therapies Inc. | 0.09% | 2,250,000 | $15.3M | New |
| MOBI Mobia Medical Inc. | 0.09% | 1,128,557 | $15.1M | New |
| NERV Minerva Neurosciences Inc. | 0.08% | 2,365,000 | $13.1M | No change |
| ALMR Alamar Biosciences Inc. | 0.07% | 462,900 | $12.5M | New |
| ALVO Alvotech SA | 0.06% | 2,859,675 | $10.6M | Add +1332.2% |
| BBNX Beta Bionics Inc. | 0.06% | 595,000 | $9.3M | Reduce -83.5% |
| IFRX Inflarx NV | 0.04% | 3,325,000 | $7.4M | New |
| SMG Scotts Miracle-Gro Co. | 0.04% | 88,000 | $6.0M | New |
| WAY Waystar Holding Corp. | 0.03% | 264,900 | $5.4M | New |
| BC Brunswick Corp. | 0.03% | 61,000 | $5.1M | New |
| GNTX Gentex Corp. | 0.03% | 199,000 | $5.0M | New |
| IDXX Idexx Laboratories Inc. | 0.03% | 9,000 | $4.7M | New |
| PRME Prime Medicine Inc. | 0.03% | 1,240,843 | $4.6M | No change |
| CMC Commercial Metals Co. | 0.02% | 67,000 | $4.2M | New |
| JATT Jatt II Acquisition Corp. | 0.02% | 300,000 | $3.4M | New |
| SGMT Sagimet Biosciences Inc. Class A | 0.02% | 415,000 | $3.2M | New |
| SMC Summit Midstream Corp. | 0.01% | 58,214 | $1.7M | No change |
| TEVA Teva Pharmaceutical-SP ADR | 0.01% | 40,000 | $1.4M | Reduce -88.7% |
| COGT Cogent Biosciences Inc. | 0.00% | 17,000 | $658K | No change |
| ANNA Aleanna Inc. | 0.00% | 78,400 | $227K | No change |
| WELL Welltower Inc. | 0.00% | 1,000 | $227K | Reduce -99.5% |
| PACB Pacific Biosciences of Calif | 0.00% | 14,200 | $24K | Reduce -89.5% |
| GERN Geron Corp. | 0.00% | 14,400 | $18K | Reduce -66.5% |
| CGC Canopy Growth Corp. | 0.00% | 18,000 | $17K | Reduce -40.0% |
| RANI Rani Therapeutics Holdings Class A | 0.00% | 20,700 | $16K | Reduce -73.5% |
| BYND Beyond Meat Inc. | 0.00% | 19,000 | $14K | No change |
Options reported separately and not counted above: SPY puts ($4.5B), SOXX puts ($83.3M), CGON calls ($28.4M).
Other holdings (9): bonds, preferreds, convertibles and warrants · $140.2M (not counted above)
| Security | Class | Shares / Principal | Value | Change |
|---|---|---|---|---|
| STRATEGY INC (MSTR 0 12/01/29) | NOTE 12/0 · principal | 87,858,000 | $75.4M | Add +122.4% |
| VNET GROUP INC | NOTE 2.000%10/0 · principal | 45,000,000 | $46.8M | No change |
| STRATEGY INC (MSTR 2.25 06/15/32) | NOTE 2.250% 6/1 · principal | 15,000,000 | $14.2M | New |
| STRATEGY INC (MSTR 0 03/01/30) | NOTE 3/0 · principal | 2,632,000 | $2.3M | New |
| RVMDW Revolution Medicines Inc.-28 | *W EXP 12/17/202 | 120,085 | $1.1M | No change |
| ANNAW Aleanna Inc. Class A - 29 | *W EXP 12/13/202 | 990,000 | $297K | No change |
| SLDPW Decarbonization Plus -CW23 | *W EXP 12/08/202 | 405,316 | $41K | No change |
| BGLWW Blue Gold Ltd. | *W EXP 04/01/203 | 255,800 | $31K | Reduce -14.7% |
| NVNWF Nvni Group Ltd.-28 | *W EXP 11/01/202 | 375,000 | $18K | No change |
Total filed on the 13F, all lines: $17.1B.
Portfolio Sells Q1 2026 → Q2 2026
| MSFT Microsoft Corp. | Reduce -52.5% | 2.45% | −2.72 |
| SCHW Schwab (charles) Corp. | Sold out | 0.00% | −2.21 |
| AON Aon PLC Class A | Reduce -45.0% | 2.71% | −2.12 |
| GOOG Alphabet Inc. Class C | Sold out | 0.00% | −1.70 |
| AMZN Amazon.com Inc. | Reduce -37.6% | 3.70% | −1.53 |
| V Visa Inc. Class A | Sold out | 0.00% | −1.51 |
| DIS The Walt Disney Co. | Sold out | 0.00% | −1.38 |
| MA Mastercard Inc. Class A | Sold out | 0.00% | −1.29 |
| MCK McKesson Corp. | Sold out | 0.00% | −1.21 |
| CNTA Centessa Pharmaceuticals Ltd. | Sold out | 0.00% | −1.14 |
| WAB Wabtec Corp. | Reduce -44.4% | 1.42% | −0.97 |
| TYRA Tyra Biosciences Inc. | Sold out | 0.00% | −0.82 |
| AVGO Broadcom Inc. | Reduce -35.3% | 2.57% | −0.71 |
| SNPS Synopsys Inc. | Reduce -31.6% | 2.18% | −0.68 |
| THC Tenet Healthcare Corp. | Sold out | 0.00% | −0.51 |
| CAH Cardinal Health Inc. | Sold out | 0.00% | −0.46 |
| PCVX Vaxcyte Inc. | Sold out | 0.00% | −0.44 |
| DNTH Dianthus Therapeutics Inc. | Sold out | 0.00% | −0.42 |
| KKR KKR & Co. Inc. | Reduce -11.8% | 2.23% | −0.34 |
| CGON CG Oncology Inc. | Sold out | 0.00% | −0.27 |
| NTRA Natera Inc. | Reduce -30.8% | 3.55% | −0.27 |
| ARMK Aramark | Reduce -40.9% | 1.22% | −0.26 |
| WELL Welltower Inc. | Reduce -99.5% | 0.00% | −0.23 |
| BBNX Beta Bionics Inc. | Reduce -83.5% | 0.06% | −0.16 |
| BITW Bitwise 10 Crypto Index ETF | Sold out | 0.00% | −0.16 |
| RPRX Royalty Pharma PLC Class A | Sold out | 0.00% | −0.14 |
| MRK Merck & Co. Inc. | Reduce -44.9% | 0.15% | −0.11 |
| NTES Netease Inc.-ADR | Reduce -57.6% | 0.09% | −0.10 |
| CECO Ceco Environmental Corp. | Sold out | 0.00% | −0.08 |
| GDS GDS Holdings Ltd. - ADR | Sold out | 0.00% | −0.07 |
| TEVA Teva Pharmaceutical-SP ADR | Reduce -88.7% | 0.01% | −0.06 |
| FORM Formfactor Inc. | Sold out | 0.00% | −0.03 |
| MTZ Mastec Inc. | Sold out | 0.00% | −0.03 |
| C Citigroup Inc. | Sold out | 0.00% | −0.03 |
| ENTG Entegris Inc. | Sold out | 0.00% | −0.03 |
| H Hyatt Hotels Corp. Class A | Sold out | 0.00% | −0.03 |
| WAL Western Alliance Bancorp | Sold out | 0.00% | −0.03 |
| TKR Timken Co. | Sold out | 0.00% | −0.03 |
| SPGI S&P Global Inc. | Sold out | 0.00% | −0.03 |
| FLEX Flex Ltd. | Sold out | 0.00% | −0.03 |
| LFUS Littelfuse Inc. | Sold out | 0.00% | −0.03 |
| PIPR Piper Sandler Cos | Sold out | 0.00% | −0.03 |
| AIR Aar Corp. | Sold out | 0.00% | −0.03 |
| GTX Garrett Motion Inc. | Sold out | 0.00% | −0.03 |
| ROL Rollins Inc. | Sold out | 0.00% | −0.03 |
| AFRM Affirm Holdings Inc. | Sold out | 0.00% | −0.03 |
| INTR Inter & Co. Inc. Class A | Sold out | 0.00% | −0.03 |
| CMI Cummins Inc. | Sold out | 0.00% | −0.03 |
| FISV Fiserv Inc. | Sold out | 0.00% | −0.03 |
| VRT Vertiv Holdings Co. Class A | Sold out | 0.00% | −0.03 |
Portfolio Buys Q1 2026 → Q2 2026
| ROIV Roivant Sciences Ltd. | Add +47.9% | 2.99% | +1.39 |
| TNGX Tango Therapeutics Inc. | Add +35.0% | 2.27% | +1.13 |
| IMVT Immunovant Inc. | Add +275.5% | 1.32% | +1.09 |
| EXEL Exelixis Inc. | Add +2.7% | 4.33% | +0.98 |
| TWST Twist Bioscience Corp. | Add +49.6% | 1.30% | +0.89 |
| GRAL Grail Inc. | Add +27.9% | 1.68% | +0.68 |
| BEAM Beam Therapeutics Inc. | Add +1.0% | 2.07% | +0.63 |
| BBIO Bridgebio Pharma Inc. | Add +14.7% | 4.72% | +0.58 |
| NVO Novo-Nordisk A/S-Spons ADR | Add +234.9% | 0.74% | +0.57 |
| TMO Thermo Fisher Scientific Inc. | Add +19.0% | 3.10% | +0.52 |
| BIDU Baidu Inc. - Spon ADR | Add +171.3% | 0.81% | +0.52 |
| EA Electronic Arts Inc. | Add +6.0% | 9.58% | +0.51 |
| ACHC Acadia Healthcare Co. Inc. | Add +143.0% | 0.74% | +0.49 |
| JNJ Johnson & Johnson | Add +175.7% | 0.61% | +0.40 |
| PBLS Parabilis Medicines Inc. | New | 0.38% | +0.38 |
| AZN Astrazeneca PLC | Add +153.4% | 0.64% | +0.38 |
| NVS Novartis AG-Sponsored ADR | New | 0.34% | +0.34 |
| BTSG Brightspring Health Services | Add +7.2% | 0.71% | +0.30 |
| GH Guardant Health Inc. | Add +3927.5% | 0.29% | +0.28 |
| AVTX Avalo Therapeutics Inc. | Add +172.7% | 0.27% | +0.19 |
| CRNX Crinetics Pharmaceuticals Inc. | Add +7.8% | 1.99% | +0.18 |
| AGIO Agios Pharmaceuticals Inc. | Add +4.1% | 1.30% | +0.15 |
| WRBY Warby Parker Inc. Class A | New | 0.15% | +0.15 |
| KLRA Kailera Therapeutics Inc. | New | 0.14% | +0.14 |
| MAZE Maze Therapeutics Inc. | Add +197.0% | 0.20% | +0.13 |
| AXTA Axalta Coating Systems Ltd. | New | 0.10% | +0.10 |
| ABVX Abivax SA-ADR | Add +6000.0% | 0.10% | +0.09 |
| BIIB Biogen Inc. | New | 0.09% | +0.09 |
| TSHA Taysha Gene Therapies Inc. | New | 0.09% | +0.09 |
| MOBI Mobia Medical Inc. | New | 0.09% | +0.09 |
| ALMR Alamar Biosciences Inc. | New | 0.07% | +0.07 |
| RIO Rio Tinto PLC-Spon ADR | Add +241.0% | 0.10% | +0.07 |
| JOYY Joyy Inc.-ADR | Add +20.9% | 0.27% | +0.07 |
| VNET Vnet Group Inc.-ADR | Add +219.6% | 0.09% | +0.06 |
| ALVO Alvotech SA | Add +1332.2% | 0.06% | +0.06 |
| ASMB Assembly Biosciences Inc. | Add +30.7% | 0.26% | +0.06 |
| IFRX Inflarx NV | New | 0.04% | +0.04 |
| SMG Scotts Miracle-Gro Co. | New | 0.04% | +0.04 |
| WAY Waystar Holding Corp. | New | 0.03% | +0.03 |
| BC Brunswick Corp. | New | 0.03% | +0.03 |
| GNTX Gentex Corp. | New | 0.03% | +0.03 |
| IDXX Idexx Laboratories Inc. | New | 0.03% | +0.03 |
| CMC Commercial Metals Co. | New | 0.02% | +0.02 |
| JATT Jatt II Acquisition Corp. | New | 0.02% | +0.02 |
| SGMT Sagimet Biosciences Inc. Class A | New | 0.02% | +0.02 |
| BSX Boston Scientific Corp. | Add +40.8% | 2.65% | −0.14 |
Options Activity Q1 2026 → Q2 2026
| SPY SS SPDR S&P 500 ETF Trust-US | put | New | 6,000,000 | $4.5B |
| STATE STR SPDR S&P 500 ETF T | put | Sold out | 2,300,000 | $1.5Bbefore exit |
| INVESCO EXCHANGE TRADED FD T | put | Sold out | 3,600,000 | $690.9Mbefore exit |
| SOXX iShares Semiconductor ETF | put | New | 130,000 | $83.3M |
| CGON CG Oncology Inc. | call | New | 400,000 | $28.4M |
| CG ONCOLOGY INC | call | Sold out | 200,000 | $13.5Mbefore exit |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
Notes & Other Activity Q1 2026 → Q2 2026
| STRATEGY INC (MSTR 0 12/01/29) | NOTE 12/0 · principal | Add +122.4% | 87,858,000 | $75.4M |
| STRATEGY INC (MSTR 2.25 06/15/32) | NOTE 2.250% 6/1 · principal | New | 15,000,000 | $14.2M |
| STRATEGY INC (MSTR 0 03/01/30) | NOTE 3/0 · principal | New | 2,632,000 | $2.3M |
| BGLWW Blue Gold Ltd. | *W EXP 04/01/203 | Reduce -14.7% | 255,800 | $31K |
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 77 | $16.9B | RVMD, EA, BBIO, PTGX, EXEL |
| Q1 2026Amended | 163 | $16.8B | EA, RVMD, AMZN, MSFT, AON |
| Q4 2025Amended | 143 | $19.2B | RVMD, MSFT, AMZN, EA, AON |
| Q3 2025Amended | 134 | $17.7B | MSFT, AON, EXEL, AMZN, NTRA |
| Q2 2025Amended | 138 | $21.9B | SPY, MSFT, NTRA, HES, AON |
| Q1 2025Amended | 139 | $18.5B | HES, MSFT, EXEL, DFS, UNH |
| Q4 2024Amended | 138 | $18.9B | HES, EXEL, UNH, DFS, NTRA |
| Q3 2024Amended | 145 | $18.0B | HES, IQV, EXEL, UNH, MSFT |
| Q2 2024Amended | 140 | $16.6B | HES, UNH, CRM, IQV, EXEL |
| Q1 2024Amended | 144 | $16.6B | HES, PXD, UNH, IQV, EXEL |